Option Care Health Jumped About 33% on a $32.05 Buyout. Why Not All the Way?
Option Care Health agreed to a $32.05 per-share cash buyout led by CD&R (about 51%) with McKesson (about 49%), at a roughly $5.8 billion enterprise value including debt. The stock jumped about 33% in early trading on October 6 but stayed about a dollar below the offer. The gap, called the deal spread, reflects time to close (expected first half of 2027), shareholder-vote, antitrust and healthcare approval risk, and the downside if the deal breaks. The piece also explains how options behave on a stock being acquired for cash, with risks and a tax note.
Option Care Health (OPCH) stock jumped about 33% in early trading, yet it stopped a dollar or so short of the buyout price. That gap is one of the cleanest lessons in how takeover pricing works.
What actually happened
Option Care Health, a home and alternate-site infusion services provider, agreed to be acquired for $32.05 per share in cash, according to the company's SEC filing. The merger agreement is dated October 5, 2026, and was announced on Tuesday, October 6.
- Buyers: Private equity firm Clayton, Dubilier & Rice (CD&R) is taking a controlling stake of roughly 51%, with McKesson holding roughly 49% as a co-investor.
- Enterprise value: The company describes it as about $5.8 billion. That figure includes debt, so it is not the same as the price paid for the shares.
The stock had already jumped about 22% after hours on Monday when news reports of a possible deal surfaced. On Tuesday it opened around $31 against a prior close of $23.37, a gain of roughly 33% in early trading. The $32.05 price is about a 37% premium to that prior close.
Price figures here are early-session snapshots from October 6, not official closing prices.
Why isn't the stock at $32.05?
If the buyer has agreed to pay $32.05 in cash, why would anyone sell at roughly $31? The difference is called the deal spread: the gap between the offer price and the current share price. It is the market's pricing of several things:
- Time. The companies expect closing in the first half of 2027. Money tied up for several months has a cost.
- Completion risk. The deal still needs a majority shareholder vote, antitrust clearance (known as HSR, for Hart-Scott-Rodino), and healthcare regulatory approvals.
- Downside if it fails. If the deal collapsed, the stock could fall back toward where it traded before the news. Nobody knows exactly where that would be.
At roughly $31, the gross spread is about $1, or around 3%. That is simple arithmetic on an intraday quote, not a forecast of anyone's return, and it ignores costs, taxes, and the chance of a delay.
A report versus a signed deal
The move came in two steps. A report that a deal was being prepared moved the stock about 22%. A signed agreement moved it roughly another 10 points. Markets price rumors at a discount for the chance nothing gets signed. A definitive agreement removes one risk, willingness, but leaves others, such as regulators, financing, and a shareholder vote.
What the contract adds
Merger agreements spell out what happens if things go wrong. Per the filing:
- Termination fee: Option Care owes about $146 million in certain circumstances, such as accepting a superior rival proposal.
- Reverse termination fee: The buyer side owes about $292 million in certain failure scenarios.
- Outside date: October 5, 2027.
These fees are not a guarantee of anything. They simply show how the parties allocated risk.
What this means for options
Options on a stock being acquired for cash behave differently from options on an ordinary stock:
- Upside may be limited. If the cash price acts as a ceiling, call options (bets on a rising price) may have limited room to pay off, though deals can be raised, topped, or broken, and option prices may already reflect that.
- Volatility often falls. Implied volatility, the market's expected size of future price swings baked into option prices, tends to drop once a price is fixed.
- Puts price the break risk. Out-of-the-money puts (bets on a falling price, struck below the current price) reflect the small chance of a deal falling apart, a risk that can erase most of a spread in one session.
- Contract details can change. Exchanges and the Options Clearing Corporation may adjust contracts for a deal. Check the specifics before assuming anything.
Buying options can mean losing the entire premium paid, and options are not suitable for every investor; the Options Clearing Corporation publishes a risk disclosure document, "Characteristics and Risks of Standardized Options." Positions tied to deal completion can lose most or all of their value if a deal is delayed or breaks, and the stock itself could fall well below its current price if that happens. Selling options carries its own risks, including losses that can exceed the premium collected. Nothing here suggests buying or selling OPCH, and the spread figures are illustrative.
Tax angle for holders
A cash buyout generally ends in a taxable sale when the deal closes. Whether any gain is short-term or long-term depends on how long the shares were held. The wash-sale rule can also matter to investors who sold at a loss and bought shares back within 30 days before or after the sale. Details vary by person, so a tax professional is the right place for specifics.
The takeaway
A deal spread is a price tag on uncertainty. A wider spread can reflect more perceived risk, and a narrower one can reflect more market confidence, but neither is a guarantee: deals have failed even at narrow spreads. Watching how a spread moves around a vote, a regulatory milestone, or a financing headline is a useful lesson in how investors price risk.
This article is educational commentary on public market events, not personalized investment, trading, or tax advice, and not a recommendation to buy or sell any security. All investing and options trading involves risk, including loss of principal.
« Back to all insights